How does Glimepiride compare to GLP-1 receptor agonists in managing diabetes in obese patients? Are there notable differences in weight or glucose outcomes?
Lakshya KumarExplorer
How does Glimepiride compare to GLP-1 receptor agonists in obese diabetics?
Share
Glimepiride, a sulfonylurea, primarily lowers blood glucose by stimulating insulin secretion. In contrast, GLP-1 receptor agonists, like liraglutide, not only improve blood glucose control but also promote weight loss in obese diabetic patients.